BR0315639A - Granulados de meloxicam solúveis em água - Google Patents

Granulados de meloxicam solúveis em água

Info

Publication number
BR0315639A
BR0315639A BR0315639-7A BR0315639A BR0315639A BR 0315639 A BR0315639 A BR 0315639A BR 0315639 A BR0315639 A BR 0315639A BR 0315639 A BR0315639 A BR 0315639A
Authority
BR
Brazil
Prior art keywords
water soluble
soluble meloxicam
meloxicam
optionally
meloxicam granules
Prior art date
Application number
BR0315639-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Martin Andreas Folger
Stefan Henke
Jeans Schmalz
Diana Christine Keilhofer
Hans-Juergen Kroff
Nina Herz
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of BR0315639A publication Critical patent/BR0315639A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Plant Substances (AREA)
BR0315639-7A 2002-10-25 2003-10-24 Granulados de meloxicam solúveis em água BR0315639A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10250081A DE10250081A1 (de) 2002-10-25 2002-10-25 Wasserlösliche Meloxicam Granulate
PCT/EP2003/011802 WO2004037264A1 (de) 2002-10-25 2003-10-24 Wasserlösliche meloxicam granulate

Publications (1)

Publication Number Publication Date
BR0315639A true BR0315639A (pt) 2005-08-30

Family

ID=32103087

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315639-7A BR0315639A (pt) 2002-10-25 2003-10-24 Granulados de meloxicam solúveis em água

Country Status (27)

Country Link
US (1) US20130005714A1 (https=)
EP (1) EP1558262B1 (https=)
JP (2) JP4856377B2 (https=)
KR (1) KR101152689B1 (https=)
CN (1) CN1708307B (https=)
AR (1) AR041717A1 (https=)
AT (1) ATE381337T1 (https=)
AU (1) AU2003276170B2 (https=)
BR (1) BR0315639A (https=)
CA (1) CA2503396C (https=)
CO (1) CO5570680A2 (https=)
CY (1) CY1107298T1 (https=)
DE (2) DE10250081A1 (https=)
DK (1) DK1558262T3 (https=)
ES (1) ES2298619T3 (https=)
HR (1) HRP20050366B1 (https=)
MX (1) MXPA05004211A (https=)
MY (1) MY136901A (https=)
PE (1) PE20040495A1 (https=)
PL (1) PL212425B1 (https=)
PT (1) PT1558262E (https=)
RU (1) RU2333744C2 (https=)
TW (1) TWI336622B (https=)
UA (1) UA81785C2 (https=)
UY (1) UY28039A1 (https=)
WO (1) WO2004037264A1 (https=)
ZA (1) ZA200502702B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CN1680427B (zh) * 2005-02-01 2010-08-11 杨喜鸿 易于水溶解的匹多莫德复盐及其制备方法
WO2007011349A1 (en) * 2005-07-15 2007-01-25 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
AU2006298895B9 (en) * 2005-09-30 2013-01-24 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
US7572641B2 (en) 2005-11-22 2009-08-11 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions comprising meloxicam and methods of their preparation
US7772255B2 (en) * 2005-12-13 2010-08-10 Supratek Pharma, Inc. Method of treating tumors with azaxanthones
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法
TR200809200A1 (tr) * 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
MX389960B (es) 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
RU2465892C1 (ru) * 2011-09-21 2012-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет (НГУ)" Способ получения высокодисперсного мелоксикама
CN103705479B (zh) * 2012-09-29 2017-11-28 瑞普（天津）生物药业有限公司 一种宠物用美洛昔康缓释片及其制备方法
RU2559000C1 (ru) * 2014-02-25 2015-08-10 Вячеслав Михайлович Спиридонов Кормовая добавка бфк
US9526734B2 (en) * 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
WO2016086114A1 (en) * 2014-11-25 2016-06-02 Artdem, Llc Sports drink formulation
US20170281640A1 (en) * 2016-04-04 2017-10-05 Productos Maver, S.A. De C.V. Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
EP3541815A4 (en) 2016-11-18 2020-07-15 Pacira Pharmaceuticals, Inc. ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME
JP2019163249A (ja) * 2018-03-16 2019-09-26 フジタ製薬株式会社 メロキシカム水性溶液

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102416A (en) * 1976-02-19 1977-08-27 Okawara Mfg Granule making method of herb medicine and like
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
JPH0753663B2 (ja) * 1984-10-09 1995-06-07 武田薬品工業株式会社 チアミン塩の顆粒，その製造法および錠剤
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0912426A (ja) * 1995-06-29 1997-01-14 Asahi Chem Ind Co Ltd 吸湿性物質組成物
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
DE19859636A1 (de) * 1998-12-23 2000-06-29 Hexal Ag Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
WO2001097812A1 (fr) * 2000-06-20 2001-12-27 Fujisawa Pharmaceutical Co., Ltd. Preparations pharmaceutiques contenant des composes tetracycliques
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate

Also Published As

Publication number Publication date
DK1558262T3 (da) 2008-01-28
EP1558262A1 (de) 2005-08-03
ATE381337T1 (de) 2008-01-15
ES2298619T3 (es) 2008-05-16
EP1558262B1 (de) 2007-12-19
KR101152689B1 (ko) 2012-06-15
DE10250081A1 (de) 2004-05-13
MY136901A (en) 2008-11-28
JP2011213726A (ja) 2011-10-27
AR041717A1 (es) 2005-05-26
CA2503396C (en) 2011-12-13
CY1107298T1 (el) 2012-11-21
AU2003276170B2 (en) 2009-07-16
ZA200502702B (en) 2008-01-30
PL375479A1 (en) 2005-11-28
HRP20050366A2 (en) 2006-06-30
CN1708307B (zh) 2011-12-07
HK1084878A1 (en) 2006-08-11
US20130005714A1 (en) 2013-01-03
DE50308863D1 (de) 2008-01-31
CA2503396A1 (en) 2004-05-06
UY28039A1 (es) 2004-05-31
HRP20050366B1 (hr) 2013-12-06
UA81785C2 (uk) 2008-02-11
TWI336622B (en) 2011-02-01
CO5570680A2 (es) 2005-10-31
AU2003276170A1 (en) 2004-05-13
PE20040495A1 (es) 2004-09-17
PT1558262E (pt) 2008-01-18
KR20050070079A (ko) 2005-07-05
MXPA05004211A (es) 2005-06-08
JP5579132B2 (ja) 2014-08-27
TW200501961A (en) 2005-01-16
JP2006505574A (ja) 2006-02-16
RU2333744C2 (ru) 2008-09-20
CN1708307A (zh) 2005-12-14
JP4856377B2 (ja) 2012-01-18
RU2005115955A (ru) 2006-02-10
WO2004037264A1 (de) 2004-05-06
PL212425B1 (pl) 2012-09-28

Similar Documents

Publication Publication Date Title
BR0315639A (pt) Granulados de meloxicam solúveis em água
DE10180655T8 (de) Phytasegranulate in der Tierernährung
BR9915208A (pt) Preparado farmacêutico de moxifloxacina
WO2005053420A3 (en) Method to reduce stool odor of companion animals
FI971083A0 (fi) Aine tuotannon lisäämiseksi eläinten kasvatuksessa ja tuotanossa siipikarjateollisuudessa
PT1149090E (pt) Nova forma cristalina do sal de potassio de (s)-omeprazole
RU2008133986A (ru) Композиции и способы профилактики и лечения хронической почечной недостаточности у кошачьих
BRPI0417958A (pt) composto, composição farmacêutica, processo para a preparação de um sal maleato, uso de um sal maleato, e, método para produzir um efeito redutor na permeabilidade antiangiogênica e/ou vascular em um animal de sangue quente
ATE261440T1 (de) Pyridinsulfonylharnstoffderivate mit herbizider wirkung
CY1111503T1 (el) Υδατικο διαλυμα οξανεξιδινης, μεθοδος παρασκευης του ιδιου, και απολυμαντικο
BR0014702A (pt) Composição de glifosato herbicida, e, método de formação de uma composição de glifosato para a aplicação a ervas daninhas
BR9913337A (pt) Derivados tan-1057
DE60018186D1 (de) Arzneimittel zur vorbeugung / behandlung / inhibierung des fortschritts für einfache oder preproliferative retinopathie
ATE478688T1 (de) Verbindungen für den transfer von oligonukleotiden
BR8400784A (pt) Derivados de feniletilamina e seus sais fisiologicamente toleraveis,processo para sua preparacao,sua aplicacao,alimentacao animal,agentes promotores do crescimento para animais,processo para preparacao de alimentacao animal,e pre-misturas para alimentacao animal
BRPI0411691A (pt) l-lisina de aztreonam e seus métodos de preparação
EA200600954A1 (ru) Способ приготовления гранул мочевины
BR0207477A (pt) Processo para prepapar ácido d- pantotênico e/ou sais do mesmo, e, composição para uso como aditivo de alimento para animal e/ou suplemento de alimento para animal
BR0113399A (pt) Processo para a preparação de um suplemento de ração animal, suplemento de ração animal, e, uso do mesmo
BR0207474A (pt) Processo para preparar ácido d-pantotênico e /ou seus sais, e, composição para o uso como aditivo de alimento para animal e/ou suplemento de alimento para animal
Hutber et al. The role of management segregations in controlling intra-herd foot-and-mouth disease
RU2003107027A (ru) Способ санации объектов ветнадзора инкубатория препаратом "брокарсепт"
BR0207473A (pt) Processo para preparar ácido d-pantotênico e/ou seus sais, e, composição para uso como aditivo de alimento para animal e/ou suplemento de alimento para animal
BR0207475A (pt) Processo para a preparação ácido d-pantotênico e /ou de seus sais, e, composição para uso como suplemento de ração de animal e/ou aditivo de ração de animal
LU90992I2 (fr) Xigris-drotrécogine alfa(activée) et ses dérivés hpharmaceutiquement acceptables

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 13 E 25 DA LPI

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.